effect of microbes on clinical outcomes of neoadjuvant treatment in patients with rectal cancer
Published 2 years ago • 64 plays • Length 1:42Download video MP4
Download video MP3
Similar videos
-
16:36
which neoadjuvant treatment in rectal cancer?
-
9:09
exploring the neoadjuvant treatment of rectal cancer
-
2:48
total neoadjuvant therapy pembrolizumab in locally-advanced rectal cancer
-
1:19
pemrec: neo-adjuvant pembrolizumab and rt in rectal cancer
-
1:34
neoadjuvant therapy and organ preservation in rectal cancer
-
4:03
phase ii trial of neoadjuvant bevacizumab modified folfox7 in rectal cancer
-
2:24
neoadjuvant therapy and the impact on laboratories
-
3:00
foxtrot: neoadjuvant folfox chemotherapy in colorectal cancer
-
2:12
the rationale behind the phase iii trial on neoadjuvant intravesical mmc treatment of bladder cancer
-
4:38
impact of neoadjuvant chemo on pathological staging and survival in sarcomatoid bladder cancer
-
1:16:10
is total neoadjuvant therapy good for everyone with rectal cancer? (graphic)
-
8:50
impact of the tumor immune microenvironment on bevacizumab benefit in colon cancer
-
1:08
nest-1: neoadjuvant botensilimab and balstilimab in colorectal cancer
-
0:31
evolving treatment algorithms in colorectal cancer
-
2:09
effects of the tumor microenvironment on therapeutic response
-
1:07
the role of the gut microbiome in modulating immunotherapy responses in melanoma
-
1:29
biomarker identification in nsclc treated with neoadjuvant chemo-io
-
17:31
total neoadjuvant therapy in rectal cancer in the community setting
-
3:26
we are our microbes!